Also known as: HMG-CoA reductase inhibitors, Cholesterol medications
Statins are the mainstay of cholesterol management and cardiovascular disease prevention. They share a class-wide pharmacogenetic story: the SLCO1B1 transporter moves statins from blood into liver cells where they work. People with reduced SLCO1B1 function accumulate statins in circulation (including in muscle), which directly drives statin-associated muscle pain (the single most common reason patients discontinue a statin).
Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.
Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.
This page covers the pharmacogenetics of statins in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.
Get your report Look up a medicationInformational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.